At Seismic Therapeutic™, we believe our unique approach to applying machine learning to biologics drug discovery will create positive change in the autoimmune landscape and the lives of patients.
Just like our approach, we are a synthesis of many things. Keenly focused and spirited, yet curious and relentless – we are open to the possibilities of the new and the uncharted. We fully believe that our impact on the drug discovery paradigm directly correlates to our willingness to embrace inclusivity and collaboration.
October 21, 2025
Seismic Therapeutic Announces Publication Demonstrating Activity of Immunoglobulin Proteases in Autoantibody-Driven Diseases Read more
June 2, 2025
Seismic Therapeutic Appoints Sophie Jones, M.D., as Chief Financial Officer Read more